The level of 11,820-11,840 is a crucial support zone. On the upside, the level of 11,980-12,000 is expected to act as a stiff resistance. Stocks in news: Infosys, Sun Pharmaceutical, Hero Motocorp, PI Industries, Quess Corp, Aditya Birla Fashion and Retail, SPARC.

This fresh capital expenditure is mainly aimed at increasing production capacities at its facilities at Roha and Mahad. This capex is likely to be funded through the blend of debt.

Breaking a five-day winning streak, Indian equity benchmarks ended the volatile day of trade marginally in red on Tuesday due to the selling in frontline blue chip stocks, despite strong trend seen in the other Asian markets.

Dabur India reported an 8% YoY rise in revenues for Q2FY20. EBIDTA grew by 27% and PAT grew by 7.2% on YoY basis. The company’s FMCG business in India reported a volume growth of 4.8%.

When it comes to investing for your financial goals or even for the wealth creation purposes, you are bound to be anxious. Many a time, this anxiety results in bad decisions that impact your investments, severely. Here, the question arises that how will you control this anxiety and protect your finances from going haywire. Read on to find out more:

The proposed capacity addition is 45,000 MTPA. The period, within which the proposed capacity is to be added, is by the end of second quarter of FY21. The project will be funded with the mix of internal accrual and debt.

Immediate support for the Nifty is placed at 11,880, followed by 11,840 levels. On the upside, the level of 11,980, followed by 12,040, would act as immediate resistance points. Stocks in news: Mahindra & Mahindra, SMS LifeSciences, Tata Power, Bajaj Finance.

The following stocks will be in focus during Tuesday’s trading session in light of their results announcements: Dabur, NCC, Titan, Ajanta Pharma and Divi’s Labs.

In the last trading sessions, the BSE Sensex recorded a fresh all-time high, whereas, the Nifty attempted to reclaim the magical figure of 12,000 mark. However, the 12,000 mark on the Nifty remained a far-fetched dream. In the overnight trade on Wall Street, all three major indices touched record highs but there is not much from Asian peers to drive the market today.

Hikal Limited announced having received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (USFDA) for its Active Pharmaceutical Ingredient (API) unit located in Bangalore.